Spectrum Pharmaceuticals, Inc.
SPPINASDAQHealthcare
$1.03
$-0.01(-0.49%)
Market Cap$210377146
P/E Ratio—
52W High$1.57
52W Low$0.32
Spectrum Pharmaceuticals, Inc. (SPPI) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SPPI · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($75.40M) | ($158.63M) | ($160.87M) | ($112.69M) | ($120.01M) |
| Depreciation & Amort. | $0.25M | $0.29M | $0.26M | $3.33M | $28.41M |
| Stock-Based Comp. | $8.49M | $19.84M | $17.82M | $21.84M | $17.48M |
| Change in Working Capital | ($35.22M) | $2.65M | ($12.53M) | ($21.89M) | $21.90M |
| Net Cash from Operations | ($96.99M) | ($119.49M) | ($121.63M) | ($134.63M) | ($62.40M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.27M) | ($0.22M) | ($5.54M) | ($9.02M) | ($2.76M) |
| Purchases of Investments | ($34.58M) | ($16.86M) | ($89.38M) | ($200.16M) | $0.00M |
| Sales of Investments | $8.13M | $125.79M | $112.99M | $82.55M | $4.13M |
| Net Cash from Investing | ($26.72M) | $108.71M | $18.07M | $31.99M | $1.37M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $75.59M | $53.31M | $85.23M | $9.63M | ($8.46M) |
| Free Cash Flow | |||||
| Free Cash Flow | ($97.26M) | ($119.71M) | ($127.16M) | ($143.65M) | ($65.16M) |
| FCF Margin %(computed) | -961.66% | — | — | -635.19% | -59.60% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Spectrum Pharmaceuticals, Inc. data
About Spectrum Pharmaceuticals, Inc. (SPPI) Cash Flow Statement
Spectrum Pharmaceuticals, Inc. generated operating cash flow of ($0.10B) and free cash flow of ($0.10B) for 2022 — a FCF margin of -961.66%. Capital expenditure was ($0.00B).
Frequently asked questions
SPPI · 4 questionsSpectrum Pharmaceuticals, Inc. generated free cash flow of ($0.10B) for 2022, up 18.7% year-over-year.
SPPI free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10